{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:10:11Z","timestamp":1762423811432,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T00:00:00Z","timestamp":1696723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004043","name":"Kanazawa Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004043","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["apjon.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asia-Pacific Journal of Oncology Nursing"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.apjon.2023.100317","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T21:22:10Z","timestamp":1697491330000},"page":"100317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Attitudes, expectations, and lived experiences of cancer patients receiving dendritic cell vaccine therapy in Japan"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4297-8181","authenticated-orcid":false,"given":"Yoshiko","family":"Kitamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chizuko","family":"Konya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.apjon.2023.100317_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apjon.2023.100317_bib2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/gutjnl-2019-320234","article-title":"Is gastric cancer becoming a rare disease?","volume":"69","author":"Arnold","year":"2020","journal-title":"Gut"},{"year":"2020","series-title":"Cancer Registry and Statistics","key":"10.1016\/j.apjon.2023.100317_bib3"},{"key":"10.1016\/j.apjon.2023.100317_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110009","article-title":"Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine","volume":"125","author":"Bashraheel","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apjon.2023.100317_bib5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","article-title":"Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update","volume":"17","author":"Clara","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apjon.2023.100317_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13402-019-00469-5","article-title":"CD47: role in the immune system and application to cancer therapy","volume":"43","author":"Hayat","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1016\/j.apjon.2023.100317_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117580","article-title":"Dendritic cell therapy in cancer treatment; the state-of-the-art","volume":"254","author":"Sadeghzadeh","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.apjon.2023.100317_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102016","article-title":"Immunotherapy for pancreatic cancer: a 2020 update","volume":"86","author":"Schizas","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.apjon.2023.100317_bib9","doi-asserted-by":"crossref","first-page":"706","DOI":"10.5858\/arpa.2018-0584-CP","article-title":"The cancer immunotherapy biomarker testing landscape","volume":"144","author":"Walk","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.apjon.2023.100317_bib10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3109\/08820139.2015.1096684","article-title":"Active immunotherapy of cancer","volume":"44","author":"Chodon","year":"2015","journal-title":"Immunol Invest"},{"key":"10.1016\/j.apjon.2023.100317_bib11","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.3390\/cells11193028","article-title":"Dendritic cells: the long and evolving road towards successful targetability in cancer","volume":"11","author":"Marmonti","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.apjon.2023.100317_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.686544","article-title":"Insights into dendritic cells in cancer immunotherapy: from bench to clinical applications","volume":"9","author":"Salah","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.apjon.2023.100317_bib13","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.3389\/fimmu.2018.02265","article-title":"Dendritic cell cancer therapy: vaccinating the right patient at the right time","volume":"9","author":"van Willigen","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.apjon.2023.100317_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-022-00257-2","article-title":"Research progress on dendritic cell vaccines in cancer immunotherapy","volume":"11","author":"Yu","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.apjon.2023.100317_bib15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3389\/fimmu.2020.00924","article-title":"Dendritic cells and their role in immunotherapy","volume":"11","author":"Gardner","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.apjon.2023.100317_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106336","article-title":"Efficacy and safety of dendritic cell vaccines for patients with glioblastoma: a meta-analysis of randomized controlled trials","volume":"83","author":"Lv","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.apjon.2023.100317_bib17","first-page":"1047","article-title":"Impact of mature dendritic cells pulsed with a novel WT1 helper peptide on the induction of HLA-A2-restricted WT1-reactive CD8+ T cells","volume":"57","author":"Kan","year":"2020","journal-title":"Int J Oncol"},{"key":"10.1016\/j.apjon.2023.100317_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00262-014-1554-7","article-title":"Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis","volume":"63","author":"Kobayashi","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.apjon.2023.100317_bib19","first-page":"989","article-title":"Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma","volume":"123","author":"Sakai","year":"2015","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.apjon.2023.100317_bib20","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/vaccines3041004","article-title":"Dendritic cell-based adjuvant vaccination targeting Wilms' tumor 1 in patients with advanced colorectal cancer","volume":"3","author":"Shimodaira","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.apjon.2023.100317_bib21","first-page":"2217","article-title":"WT1-pulsed dendritic cell vaccine combined with chemotherapy for resected pancreatic cancer in a Phase I study","volume":"38","author":"Yanagisawa","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.apjon.2023.100317_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/2326-6066.CIR-17-0386","article-title":"Combination gemcitabine and WT1 peptide vaccination improves progression-free survival in advanced pancreatic ductal adenocarcinoma: a phase ii randomized study","volume":"6","author":"Nishida","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.apjon.2023.100317_bib23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/vaccines7030120","article-title":"In vivo administration of recombinant human granulocyte colony-stimulating factor increases the immune effectiveness of dendritic cell-based cancer vaccination","volume":"7","author":"Shimodaira","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.apjon.2023.100317_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/pharmaceutics12040305","article-title":"Dendritic cells pre-pulsed with Wilms' Tumor 1 in optimized culture for cancer vaccination","volume":"12","author":"Koya","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apjon.2023.100317_bib25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jama.2016.9797","article-title":"United States health care reform. Progress to date and next steps","volume":"316","author":"Obama","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.apjon.2023.100317_bib26","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1111\/jocn.13461","article-title":"A\u00a0study on the predictors of Korean male students' intention to receive human papillomavirus vaccination","volume":"25","author":"Choi","year":"2016","journal-title":"J\u00a0Clin Nurs"},{"key":"10.1016\/j.apjon.2023.100317_bib27","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1111\/jocn.12871","article-title":"Human papillomavirus vaccine acceptability among female undergraduate students in China: the role of knowledge and psychosocial factors","volume":"24","author":"Gu","year":"2015","journal-title":"J\u00a0Clin Nurs"},{"key":"10.1016\/j.apjon.2023.100317_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/jocn.15094","article-title":"Education, income and occupation and their influence on the uptake of cervical cancer prevention strategies: a systematic review","volume":"29","author":"Murfin","year":"2020","journal-title":"J\u00a0Clin Nurs"},{"key":"10.1016\/j.apjon.2023.100317_bib29","first-page":"1845","article-title":"Certainty within uncertainty: a qualitative study of the experience of metastatic melanoma patients undergoing pembrolizumab immunotherapy","volume":"27","author":"Levy","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.apjon.2023.100317_bib30","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1002\/cam4.2940","article-title":"Cancer patients' experiences with immune checkpoint modulators: a qualitative study","volume":"9","author":"Ala-Leppilampi","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.apjon.2023.100317_bib31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/pon.6093","article-title":"A\u00a0new landscape in illness uncertainty: a systematic review and thematic synthesis of the experience of uncertainty in patients with advanced cancer receiving immunotherapy or targeted therapy","volume":"32","author":"Langmuir","year":"2023","journal-title":"Psycho Oncol"},{"key":"10.1016\/j.apjon.2023.100317_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s41927-020-00133-8","article-title":"Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps","volume":"4","author":"Cappelli","year":"2020","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.apjon.2023.100317_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12885-022-10458-x","article-title":"Patient perspectives on considerations, tradeoffs, and experiences with multiple myeloma treatment selection: a qualitative descriptive study","volume":"23","author":"Dombeck","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.apjon.2023.100317_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.pec.2023.107622","article-title":"Between hope and reality: how oncology physicians and information providers of a cancer information service\u00a0manage patients' expectations for and experiences with immunotherapies","volume":"109","author":"Ihrig","year":"2023","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.apjon.2023.100317_bib35","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1007\/s00432-020-03336-1","article-title":"Patient expectations are better for immunotherapy than traditional chemotherapy for cancer","volume":"146","author":"Ihrig","year":"2020","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.apjon.2023.100317_bib36","article-title":"Living in the twilight zone: a qualitative study on the experiences of patients with advanced cancer obtaining long-term response to immunotherapy or targeted therapy","author":"Zwanenburg","year":"2022","journal-title":"J\u00a0Cancer Surviv"},{"key":"10.1016\/j.apjon.2023.100317_bib37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/bjd.21670","article-title":"Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma","volume":"187","author":"Kamminga","year":"2022","journal-title":"Br J Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.apjon.2023.100317_bib38","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1182\/blood-2022-159836","article-title":"Understanding the patient experience of those who have undergone or considered CAR T-cell therapy in the United States: CAR T-Cell Therapy Patient Engagement Project (CPEP)","volume":"140","author":"Messina","year":"2022","journal-title":"Blood"},{"year":"1979","series-title":"Research in Nursing Practice","author":"Diers","key":"10.1016\/j.apjon.2023.100317_bib39"},{"year":"2004","series-title":"Nursing Research: Principles and Methods","author":"Polit","key":"10.1016\/j.apjon.2023.100317_bib40"},{"year":"2002","series-title":"Qualitative Research in Nursing","author":"Holloway","key":"10.1016\/j.apjon.2023.100317_bib41"},{"year":"1999","series-title":"Qualitative Research in Nursing","author":"Streubert","key":"10.1016\/j.apjon.2023.100317_bib42"},{"key":"10.1016\/j.apjon.2023.100317_bib43","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/nop2.275","article-title":"Qualitative thematic analysis based on descriptive phenomenology","volume":"6","author":"Sundler","year":"2019","journal-title":"Nurs Open"},{"key":"10.1016\/j.apjon.2023.100317_bib44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.apjon.2023.100317_bib46","series-title":"Existential-Phenomenological Alternatives for Psychology","first-page":"48","article-title":"Psychological research as a phenomenologist views it","author":"Colaizzi","year":"1978"},{"year":"1985","series-title":"Naturalistic Inquiry","author":"Lincoln","key":"10.1016\/j.apjon.2023.100317_bib47"},{"key":"10.1016\/j.apjon.2023.100317_bib48","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.apjon.2023.100317_bib49","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1186\/s12885-019-6181-4","article-title":"Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority","volume":"19","author":"Niedzwiedz","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.apjon.2023.100317_bib50","doi-asserted-by":"crossref","first-page":"9722","DOI":"10.3390\/curroncol29120763","article-title":"Fatigue, emotional distress, and illness uncertainty in patients with metastatic cancer: results from the prospective NEOETIC_SEOM study","volume":"29","author":"Rodriguez-Gonzalez","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.apjon.2023.100317_bib51","first-page":"1011","article-title":"Cancer symptom clusters--a dynamic construct","volume":"15","author":"Kirkova","year":"2007","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.apjon.2023.100317_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5172\/conu.2011.39.1.75","article-title":"Meanings and aspects of quality of life for cancer patients: a descriptive exploratory qualitative study","volume":"39","author":"Bahrami","year":"2011","journal-title":"Contemp Nurse"},{"key":"10.1016\/j.apjon.2023.100317_bib53","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa1204410","article-title":"Patients' expectations about effects of chemotherapy for advanced cancer","volume":"367","author":"Weeks","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.apjon.2023.100317_bib54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3949\/ccjm.78a.10053","article-title":"Symptom management: an important part of cancer care","volume":"78","author":"Shoemaker","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.apjon.2023.100317_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2020.101837","article-title":"Cancer patients' experiences on self-management of chemotherapy treat-related symptoms: a systematic review and thematic synthesis","volume":"49","author":"Magalhaes","year":"2020","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.apjon.2023.100317_bib56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejon.2017.07.007","article-title":"Symptom clustering and quality of life in patients with ovarian cancer undergoing chemotherapy","volume":"30","author":"Nho","year":"2017","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.apjon.2023.100317_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.critrevonc.2015.12.012","article-title":"A\u00a0systematic literature review of the economic implications of chemotherapy-induced diarrhea and its impact on quality of life","volume":"99","author":"Tarricone","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.apjon.2023.100317_bib58","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1200\/JCO.21.00165","article-title":"Decision making in older adults with cancer","volume":"39","author":"DuMontier","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.apjon.2023.100317_bib59","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/jocn.14762","article-title":"Effectiveness of nursing interventions among patients with cancer: an overview of systematic reviews","volume":"28","author":"Tuominen","year":"2019","journal-title":"J\u00a0Clin Nurs"},{"key":"10.1016\/j.apjon.2023.100317_bib60","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.soncn.2018.06.012","article-title":"Advance care planning and end-of-life decision making for patients with cancer","volume":"34","author":"Agarwal","year":"2018","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.apjon.2023.100317_bib61","doi-asserted-by":"crossref","first-page":"96","DOI":"10.12968\/bjon.2020.29.2.96","article-title":"Advance care planning","volume":"29","author":"Merlane","year":"2020","journal-title":"Br J Nurs"},{"key":"10.1016\/j.apjon.2023.100317_bib62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pop.2019.05.003","article-title":"Communication skills: delivering bad news, conducting a goals of care family meeting, and advance care planning","volume":"46","author":"Baran","year":"2019","journal-title":"Prim Care"},{"key":"10.1016\/j.apjon.2023.100317_bib63","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1177\/1049909118760303","article-title":"Provider tools for advance care planning and goals of care discussions: a systematic review","volume":"35","author":"Myers","year":"2018","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.apjon.2023.100317_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2022.102260","article-title":"Nursing care and nurses' understandings of grief and bereavement among patients and families during cancer illness and death - a scoping review","volume":"62","author":"Madsen","year":"2023","journal-title":"Eur J Oncol Nurs"},{"issue":"3","key":"10.1016\/j.apjon.2023.100317_bib65","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/SPC.0000000000000664","article-title":"Effectiveness of dignity therapy in the context of culturally competent care in people with palliative care needs: a systematic review of systematic reviews","volume":"17","author":"Johnston","year":"2023","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.apjon.2023.100317_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2022.104273","article-title":"The effectiveness of dignity therapy on hope, quality of life, anxiety, and depression in cancer patients: a meta-analysis of randomized controlled trials","volume":"132","author":"Zhang","year":"2022","journal-title":"Int J Nurs Stud"},{"year":"1997","series-title":"Philosophia Medicinae","author":"Shimizu","key":"10.1016\/j.apjon.2023.100317_bib67"}],"container-title":["Asia-Pacific Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S234756252300135X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S234756252300135X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:05:33Z","timestamp":1762423533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S234756252300135X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":66,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S234756252300135X"],"URL":"https:\/\/doi.org\/10.1016\/j.apjon.2023.100317","relation":{},"ISSN":["2347-5625"],"issn-type":[{"type":"print","value":"2347-5625"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attitudes, expectations, and lived experiences of cancer patients receiving dendritic cell vaccine therapy in Japan","name":"articletitle","label":"Article Title"},{"value":"Asia-Pacific Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apjon.2023.100317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of Asian Oncology Nursing Society.","name":"copyright","label":"Copyright"}],"article-number":"100317"}}